To assess if PRDM6 is a driver of Group 4 medulloblastoma, we set out to elucidate the functional impact and oncogenic potential of sustained PRDM6 expression in human neuroepithelial stem (NES) cells. Here, PRDM6 is linked to medulloblastoma.